Papers/PMID:9356027
Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.
Diabetes1997The record
3 findings · 1 compound · 3 endpoints
What it reported
How to read these marksWhat moved
3 findings
chromium(3+) — decreases total cholesterol (TC)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“Plasma total cholesterol also decreased after 4 months in the subjects receiving 19.2 micromol/day Cr.”
Quoted verbatim from Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.. - Study
- RCT
- Duration
- 4 months
- Dose
- 19.2 micromol Cr per day (about 1,000 microg/day)
- Population
- 180 men and women being treated for type 2 diabetes, continuing their normal medications; highest-dose group (19.2 micromol Cr per day) at 4 months
Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.1997PMID:9356027Permalink
chromium(3+) — decreases glycated haemoglobin (HbA1c)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“HbA1c values improved significantly after 2 months in the group receiving 19.2 pmol (1,000 microg) Cr per day and was lower in both chromium groups after 4 months (placebo, 8.5 +/- 0.2%; 3.85 micromol Cr, 7.5 +/- 0.2%; 19.2 micromol Cr, 6.6 +/- 0.1%).”
Quoted verbatim from Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.. - Study
- RCT
- Duration
- 4 months
- Dose
- 100 microg or 500 microg Cr twice daily (200 or 1,000 microg/day)
- Population
- 180 men and women being treated for type 2 diabetes, continuing their normal medications; 4-month timepoint, both chromium dose groups versus placebo
Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.1997PMID:9356027Permalink
chromium(3+) — decreases fasting blood glucose
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×4“Fasting glucose was lower in the 19.2-micromol group after 2 and 4 months (4-month values: placebo, 8.8 +/- 0.3 mmol/l; 19.2 micromol Cr, 7.1 +/- 0.2 mmol/l).”
Quoted verbatim from Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.. - Study
- RCT
- Duration
- 4 months
- Dose
- 19.2 micromol Cr per day (about 1,000 microg/day)
- Population
- 180 men and women being treated for type 2 diabetes, continuing their normal medications; highest-dose group (19.2 micromol Cr per day) versus placebo
Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.1997PMID:9356027Permalink